Description

 

During this conference the audience will learn about the multi-disciplinary approach for the management in pediatric and adult patients with malignant brain tumors.  The following will be reviewed, among others:

·                     Current standard of care in regards to surgery, radiation and chemotherapy;

·                     Novel imaging techniques and their role in diagnosis and follow up in gliomas and metastatic disease;

·                     Innovations in radiation techniques for the treatment of patients with gliomas and metastatic disease;

·                     Current active clinical trials for malignant brain tumors and areas of further investigation for clinical trial;

·                     The evolving role of vaccines in the treatment of gliomas;

·                     The neuropsychological effects of treatment;

·                     Pediatric gliomas.

 

 of this course, participants should be able to:

AGENDA:

7:00 – 8:00                     Registration/Continental Breakfast/Exhibits

 

8:00 – 8:15                     Welcome and Introductions

                                      Margie Gerena-Lewis, MD, Course Director

                                      Assistant Professor

                                      Hematology/Oncology Division

                                      University of Cincinnati Academic Health Center

 

A five minute Q&A is included with the presentation time

 

8:15 – 8:45                    Advances in Neuro-Imaging for Brain Tumors

                                    Mary Gaskill-Shipley, MD

                                    Associate Professor of Radiology

                                    University of Cincinnati Department of Radiology

                                    Mayfield Imaging Center, and The Neuroscience Institute

 

8:45 – 9:15                    Brain Tumor Surgery in the 21^st Century Operating Room

                                    Christopher McPherson, MD

                                    Assistant Professor of Neurosurgery

                                    University of Cincinnati Academic Health Center, Mayfield Clinic and The Neuroscience Institute

                       

9:15 – 9:45                    Radiotherapy Management of Gliomas and Metastatic Disease

                                    John Breneman, MD

                                    Charles M. Barrett Professor of Radiation Oncology

                                    University of Cincinnati Academic Health Center and The Neuroscience Institute

 

9:45 – 10:15                  Chemotherapy for Adult Brain Tumors

                                    Margie Gerena-Lewis, MD

                                    Assistant Professor of Hematology/Oncology

                                    University of Cincinnati Academic Health Center

                                   

10:15 – 10:30                BREAK AND EXHIBITS

 

10:30 – 11:00                New Directions in Treatment of Pediatric Gliomas

                                    Lars Wagner, MD

                                    Associate Professor of Pediatrics

                                    Cincinnati Children’s Hospital Medical Center

 

11:00 – 11:30                Neuropsychological Late Effects

                                    Douglas Ris, Ph D, ABPP/CN

                                    Director, Neuropsychology Program

                                    Professor of Pediatrics

                                    Cincinnati Children’s Hospital Medical Center

                       

11:30 – 12:00                Local Therapy Options for Malignant Brain Tumors

                                    Ronald E. Warnick, MD

                                    Professor of Neurosurgery and Radiation Oncology

                                    The Neuroscience Institute, University of Cincinnati Academic Health Center, and Mayfield Clinic

 

12:00 – 12:30                Future Advances in Neuro-Oncology

                                    Margie Gerena-Lewis, MD

                                    Assistant Professor of Hematology/Oncology

                                    University of Cincinnati Academic Health Center

 

12:30 – 12:40                SHORT BREAK; RETRIEVE BOX LUNCHES & RETURN TO CONFERENCE ROOM

 

12:40 – 1:10                  Case Studies (from audience)

                                    Moderators:  Drs. Lewis and McPherson

                                    Panelists:  All presenters

 

1:15                              Adjourn/Evaluations

 

 

GUEST FACULTY:

 

John C. Breneman, M.D. earned his MD at the University of Iowa School of Medicine and completed his residency in Radiation Oncology at the University of Cincinnati Academic Health Center (UCAHC). He is licensed in Ohio and Kentucky and is board certified in Therapeutic Radiology by the American Board of Radiology. Included in his honors and awards is being selected by his peers as one of the "Best Doctors in America" (1996-1999; 2003-2007).

Dr. Breneman's primary research interests are brain tumors and pediatric malignancies and he is the Principal Investigator or Co-investigator of several clinical trials at the University of Cincinnati. He is a member of many professional societies, including the Society for Neuro-oncology, International Society of Pediatric Radiation Oncology, and the Acoustic Neuroma Association. Additionally, he is very active in the Children's Oncology Group where, in addition to designing and administering clinical trials, he serves as a member of the Radiation Oncology Steering Committee, and chairs the Radiation Oncology Education Committee.

In addition to numerous local, national and international presentations, he has authored or co-authored over 80 publications and book chapters.

---

Mary Gaskill-Shipley, M.D. graduated from the University of Cincinnati Academic Health Center (UCAHC) in 1985 and completed both a Radiology residency and a Neuroradiology fellowship at UCAHC. She received board certification in Radiology in 1988 and achieved a certificate of added qualification in Neuroradiology in 1995.

Dr. Gaskill-Shipley's primary research interests are Neuro-oncology and Interventional / Intraoperative MRI imaging. She is part of a multidisciplinary panel that reviews imaging procedures and plans future therapies for brain tumor patients who are referred to the Neuro-oncology tumor board. This panel also reviews patients for possible inclusion in research treatment programs.

Dr. Gaskill-Shipley is also a co-investigator for the Interventional/Intraoperative MRI program. At UCAHC, an intraoperative MRI suite was designed to provide both open diagnostic MRI imaging as well as interventional and surgical capabilities for the Radiology and Neurosurgical departments. Intraoperative imaging helps the neurosurgeon achieve maximal resection of brain and pituitary tumors by allowing assessment of the operative results during the procedure. Due to the success of this new technology, a new dedicated intraoperative system is planned at University Hospital in the near future.

---

Margie Gerena-Lewis, M.D. graduated from Wayne State University School of Medicine and completed her Hematology/Oncology Fellowship at the University of Cincinnati Academic Health Center (UCAHC).

Dr. Gerena-Lewis is the principal investigator and co-investigator of many clinical trials at UCAHC focusing on malignant brain tumors. She is also staff at Children’s Hospital of Cincinnati in the ATP 5+ Late Effects Clinic.

She is a member of various committees at UCAHC, including the UC Brain Tumor Steering Committee, Cancer Care Committee, and the Laboratory Advisory Committee. Also participates in National committees such as the RTOG Brain Committee and the Society for Neuro-oncology International Outreach Committee. Dr. Gerena-Lewis has received numerous awards and is a member of several professional organizations such as the American Medical Association, Society for Neuro-Oncology, American Society of Clinical Oncology and American Society of Hematology.

Dr. Gerena-Lewis presents lectures throughout the University and United States.

---

Christopher McPherson, M.D. graduated from the University of Kansas School of Medicine, completed his Neurosurgery residency at the University of Cincinnati Academic Health Center (UCAHC), and earned his Neuro-Oncologic Surgery Fellowship at The University of Texas M.D. Anderson Cancer Center.

Dr. McPherson’s medical specialty is neurosurgery with special interest in cranial and spinal tumors, sterotactic radiosurgery, and general and complex degenerative spinal disorders. Research interests include malignant brain tumors, especially glioblastomas multiforme and metastatic tumors.

He participated in several research studies while attending the University of Kansas and continues his glioma research at UCAHC. Dr. McPherson has presented research findings via posters and oral presentations, and he is the author and co-author of several peer reviewed publications.

---

M. Douglas Ris, Ph. D is Professor of Pediatrics at Cincinnati Children's Hospital Medical Center and the University of Cincinnati Academic Health Center, and he is director of the Neuropsychology Program and Neuropsychology Postdoctoral Fellowship.

Dr. Ris also holds a joint appointment in the Psychology Department, University of Cincinnati. He received his PhD in clinical psychology from Wayne State University in Detroit and completed internships at the Henry Ford Hospital in Detroit and in the Department of Psychiatry, College of Human Medicine, Michigan State University.

Dr. Ris graduated magna cum laude from Michigan State University. He is a diplomate of the American Board of Clinical Neuropsychology (ABCN) and American Board of Professional Psychology (ABPP). Dr. Ris is a founding member of the Association of Postdoctoral Programs in Clinical Neuropsychology.

Dr. Ris has authored more than 35 scientific papers and book chapters. Research interests include the neurobehavioral effects of medical conditions including sickle cell anemia, brain tumors, metabolic disorders and environmental toxins.

---

Lars M. Wagner, M.D. is Associate Professor of Pediatrics in the Division of Pediatric Hematology/Oncology at Cincinnati Children's Hospital. He earned his MD from the University of Kentucky College of Medicine and completed his Pediatric Hematology/Oncology Fellowship at St. Jude Children's Research Hospital in Memphis, TN.

Dr. Wagner is a member of several professional societies, including the American Academy of Pediatrics, American Society of Pediatric Hematology/Oncology, and American Society of Clinical Oncology. In addition to several teaching awards, he received the Brigid Leventhal Merit Award for Research in Pediatric Oncology, presented by the American Society of Clinical Oncology, in2001. He is certified by the National Board of Medical Examiners, American Board of Pediatrics, and the American Board of Pediatrics/Hematology-Oncology.

He is a journal referee for Pediatric Blood & Cancer, International Journal of Oncology, and the Journal of Pediatric Hematology/Oncology, among others, and serves as a protocol reviewer for the Pediatric Brain Tumor Consortium. Dr. Wagner has authored publications, abstracts, and book chapters; he continues to be an invited speaker through the United States and Canada.

---

Ronald E. Warnick, M.D., is Chairman of the Mayfield Clinic and a neurosurgeon with The Neuroscience Institute at University Hospital and the University of Cincinnati (UC). He also serves as Professor of Neurosurgery at UC, Director of the UC Brain Tumor Center, and Co-Director of the Precision Radiotherapy Center in West Chester, Ohio. Dr. Warnick specializes in the treatment of brain tumors, and his clinical research into new treatments for glioblastoma multiforme and metastatic brain tumors has been widely published in peer-reviewed journals.

Dr. Warnick earned his MD with honors from the University of Rochester, in Rochester, NY. He completed his internship in general surgery and neurosurgery residency at New York University and his neuro-oncology fellowship at the University of California, San Francisco. He came to Cincinnati in 1991 as Director of the Division of Surgical Neuro-Oncology and has held that position ever since.

In 2000, Dr. Warnick received the Mahaley Clinical Research Award and the National Brain Tumor Foundation Award for Excellence in Clinical Research. He served as Chairman of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors from 2005 to 2007. He has given more than 100 national or international presentations, has authored eight book chapters and has trained more than 30 neurosurgical residents and neuro-oncology fellows.

 

 

LOCATION:

The symposium will be held at the Marriott Northeast, 9664 Mason-Montgomery Road, Cincinnati, Ohio 45040.

 

Driving directions

From South: Take I-71 N to Exit 19 Mason-Montgomery Road/Fields Ertel Road.  Turn left off the exit and hotel is ¼ mile ahead on the right, behind Applebee’s.

 

From North:  Take I-71 S to Exit 19 Mason-Montgomery Road/Fields Ertel Road.  Turn right off the exit and hotel is ¼ mile ahead on the right, behind Applebee’s.

 

Lodging

A block of rooms for $109 per night is reserved at Marriott Northeast, Cincinnati, Ohio for Friday, May 16, 2008 with checkout by noon on May 17.   Room reservations must be received by April 25 in order to obtain the group rate.  Call (513) 459-3000 and identify yourself with the Neuro-Oncology Symposium/University of Cincinnati.

 

 

 

TARGETED AUDIENCE: 

This program is directed to adult and pediatric neurology, neurological surgeons, neuro-ophthamology, physical medicine and rehab, emergency medicine & critical care,  medical oncology, radiation oncology, general radiology, interventional radiology, fellows in training with research & management interest in gliomas and metastatic disease, nurses, fellows,  researchers, and ancillary personnel who are interested in the treatment of gliomas and metastatic tumors.

 

ACCREDITATION:

The University of Cincinnati designates this educational activity for a maximum of 4.5 AMA PRA Category 1 Credits ^TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.   The University of Cincinnati Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians. The University of Cincinnati is committed to resolving all conflict of interest issues which may arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s).  The University of Cincinnati mandate is to retain only those speakers with financial interests that can be reconciled with the goals and educational integrity of the program.

  

ACCREDITATION STATEMENT:

The University of Cincinnati is committed to resolving all conflict of interest issues which may arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s).  The University of Cincinnati mandate is to retain only those speakers with financial interests that can be reconciled  with the goals and educational integrity of the program.